VR-guided mindfulness for anxiety, sleep, comfort, and fatigue in women with breast cancer undergoing chemotherapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines a virtual reality–integrated mindfulness intervention in women with newly diagnosed breast cancer who are about to start or are starting chemotherapy. The trial aims to measure changes in anxiety, comfort, sleep quality, and fatigue as the primary outcomes. Participants will undergo a VR mindfulness program to see if it can alleviate chemotherapy-related symptoms. The study is conducted at a single institutional site in Ankara, Turkey, with specific eligibility criteria to ensure participant safety and relevance. Results could inform supportive care options for patients undergoing chemotherapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Newly diagnosed with breast cancer, Female and aged 18 years or older, Diagnosed with stage II or III breast cancer, Scheduled to receive chemotherapy for breast cancer for the first time in the adjuvant or neoadjuvant setting, using either the CA regimen \[C: cyclophosphamide; A: doxorubicin (Adriamycin)\] or the TC regimen \[T: docetaxel; C: cyclophosphamide\], with or without paclitaxel, trastuzumab, docetaxel, or carboplatin, Scheduled to receive chemotherapy but have not yet started treatment, Have a Beck Depression Inventory (BDI) score of ≤30, have no physician-diagnosed psychiatric disorder according to the DSM-5 diagnostic criteria, and are not receiving treatment for a psychiatric disorder (Appendix 8), Have completed at least primary school education, Voluntarily agree to participate in the study.

Exclusion Criteria:

Presence of metastasis, History of seizures, Presence of vertigo, Presence of motion sickness with a tendency toward nausea and vomiting, Communication difficulties, including hearing, visual, or speech impairments, Unwillingness to participate in the study. Withdrawal Criteria

Participants will be withdrawn from the study if:

They discontinue the treatment protocol at any stage, Their treatment protocol is changed, They no longer wish to continue participating in the study.

Where it's running

• Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital, Ministry of Health, Republic of Turkey
  Ankara, Ankara, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: GİZEM CANSIZ UÇAR, Registered Nurse
• Email: gizem.cansiz@atilim.edu.tr
• Phone: +905342396480

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gait Changes in Breast Cancer Patients Receiving Chemotherapy

  This study tests how chemotherapy affects walking and balance in women with breast cancer.

  Recruiting Cairo University · Cairo, Cairo Governorate · NCT07894133

• Electroacupuncture plus self-acupressure to improve quality of life during chemotherapy for early-stage breast cancer

  This trial tests whether adding electroacupuncture together with self-acupressure can improve quality of life for people with early-stage breast cancer who are receiving chemotherapy.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT06601621

• Combining targeted therapies for solid tumors using CDK4/6 inhibitors and anti-VEGF agents

  This study is testing if combining two cancer treatments, Palbociclib and Bevacizumab, can help people with solid tumors like colorectal, breast, and ovarian cancers feel better and respond better to treatment.

  Recruiting at 2 sites Phase 1 Lebanese University · Tripoli, North Lebanon and 1 other locations · NCT06307249

• Comparing axillary radiotherapy and lymphadenectomy in breast cancer patients after neoadjuvant therapy

  This study is testing whether using axillary radiotherapy instead of surgery can help breast cancer patients who have had neoadjuvant treatment avoid lymphedema.

  Recruiting at 57 sites Hospital Universitari de Bellvitge · Sydney, New South Wales and 60 other locations · NCT04889924

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.